S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag

Dow Jones12-24

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, UiPath Inc. (PATH) was up 8.1% in pre-market trading, and CCC Intelligent Solutions Holdings Inc. (CCC) was up 4.4%.

Avery Dennison Corp. $(AVY)$, Regencell Bioscience Holdings Ltd. (RGC), and Glaukos Corp. (GKOS) were all posting gains of at least 2%. In early trading, United Therapeutics Corp. $(UTHR)$ and Intel Corp. $(INTC)$ had posted declines, falling 8.3% and 3.1%, respectively.

Meanwhile S&P 500 futures were down 0.01%, with futures for the Dow Jones Industrial Average falling 0.05%. The Cboe Volatility Index futures were up 0.30%.

In commodities news, Brent crude oil futures were up 0.26%, and gold futures were up 0.39%. Bitcoin slipped 0.44% to $87,256.

The 10-Year Treasury yield dropped to 4.165%.

In the previous regular trading session, the S&P 500 and the Dow were up 0.46% and 0.16%, respectively. Stocks in Asia were mixed overnight, with Japan's NIKKEI 225 Index down 0.14% and China's Shanghai Composite Index up 0.53%.

In afternoon trading, stocks in Europe are mixed, with the STOXX Europe 600 Index rising 0.04% and the FTSE 100 Index dropping 0.16% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled December 24, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 24, 2025 07:31 ET (12:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment